Ribonucleotide reductase small subunit M2 is a master driver of aggressive prostate cancer

Although there are molecularly distinct subtypes of prostate cancer, no molecular classification system is used clinically. The ribonucleotide reductase small subunit M2 (RRM2) gene plays an oncogenic role in many cancers. Our previous study elucidated comprehensive molecular mechanisms of RRM2 in p...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Mol Oncol
Egile Nagusiak: Mazzu, Ying Z., Armenia, Joshua, Nandakumar, Subhiksha, Chakraborty, Goutam, Yoshikawa, Yuki, Jehane, Lina E., Lee, Gwo‐Shu Mary, Atiq, Mohammad, Khan, Nabeela, Schultz, Nikolaus, Kantoff, Philip W.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley and Sons Inc. 2020
Gaiak:
Research Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7400792/
https://ncbi.nlm.nih.gov/pubmed/32385899
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/1878-0261.12706
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak